Cancer Risk clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
Mirai-MRI: Validation of AI Models for Breast Cancer Risk
Sorry, not yet accepting patients
This is a multi-center, single arm trial to evaluate the cancer detection rate of supplemental screening magnetic resonance imaging (MRI) in participants who are high-risk by Mirai-MRI assessment. Mirai is an accurate cancer risk model based on full-resolution mammograms.
San Francisco, California and other locations
Our lead scientists for Cancer Risk research studies include Maggie Chung, MD.
Last updated: